Company / Working Capital per Share
Vistagen Therapeutics, Inc. Working Capital per Share History
FY2011-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$2.34
FY2021
5-year range
$1.29 / $2.34
FY2017-FY2021
Trend
+25.0%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has increased for 5 consecutive years, from $-0.56 in FY2011 to $2.34 in FY2021.
Based on SEC 10-K filings.
2.34 in FY2021 with a 3-year CAGR of +7.7%.
Improved from $1.29 to $2.34 over the past 4 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +7.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Vistagen Therapeutics, Inc.'s working capital per share has grown for 5 consecutive years.
- In FY2021, working capital per share increased 25.0% year-over-year.
- Lowest working capital per share in the period was in FY2011.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $2.34 | +25.0% |
| FY2018 | $1.88 | +45.5% |
| FY2017 | $1.29 | +1439.7% |
| FY2014 | -$0.10 | +63.7% |
| FY2012 | -$0.27 | +52.8% |
| FY2011 | -$0.56 | - |
As of FY2021 · SEC 10-K · Updated Jun 28, 2026